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ABSTRACT 
 
Christopher Ryan Brooks: The Effect of a CPET Familiarization Session on Aerobic Capacity 
(VO2MAX) in Sedentary Middle-Aged Females 
(Under the direction of Claudio L. Battaglini) 
 
 
Cardiorespiratory capacity (VO2Max) is assessed by performing a cardiorespiratory exercise test 
(CPET). Research postulates that a learning effect can compromise the accuracy of the CPET. 
Healthy populations produce high CPET reproducibility, whereas clinical populations are 
inconclusive. The purpose of this study was to examine the effect of a familiarization session on 
aerobic capacity in sedentary middle-aged females. This study recruited 6 female participants 
ages 35-65. Test protocol consisted of a familiarization session, a VO2Max pre-test, and a VO2Max 
post-test. VO2Max, respiratory exchange ratio (RER), and maximal heart rate (HRMax) were 
analyzed using a paired samples t-tests. Relative and absolute VO2Max significantly decreased by 
-9.68% (p=0.03) and -9.33% (p=0.03), from pre to post. No significant differences were 
observed for RER and HRMax (p=0.23; p=0.30). This potentially indicates the familiarization 
effectively mitigated a learning effect; however, due to the small sample size a larger sample is 
necessary to re-evaluate these preliminary findings.
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CHAPTER I 
 
INTRODUCTION 
Aerobic Capacity 
Maximal oxygen uptake was coined in the 1920’s by A.V. Hill (Hill and Lupton, 1923) 
and defined as the maximal capacity (VO2Max) of the body to transport and utilize oxygen during 
exercise. VO2Max can be assessed by performing a graded cardiopulmonary exercise test (CPET). 
It is considered by many exercise scientists to be the gold standard of cardiovascular fitness 
(Powers and Howley, 2012).  VO2Max testing has many implications within the field of Exercise 
Physiology and it is considered the best single measurement of overall fitness of an individual. In 
the scientific literature, an increase in VO2Max is the most common method of demonstrating a 
training effect on improving overall fitness. In addition, VO2Max is frequently used in the 
development of aerobic training exercise prescription. Furthermore, cardiorespiratory capacity 
has been associated with the development of chronic diseases (Morris et al., 1953), and all cause 
mortality in individuals with low VO2Max (Myers et al., 2002; Gulati et al., 205). Most recently, 
VO2Max has been proposed to be an independent factor that predicts post-treatment complications 
and mortality in lung and bone marrow transplant cancer patients (Jones et al. 2008; Wood et al., 
2013). Given these applications of CPET, there has been great interest in identifying the 
physiological factors that limit VO2Max and determining the role of this variable in endurance 
performance (Howley et al., 1995) and many other applications associated with overall health.  
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Maximal Exercise Testing 
Oxygen uptake (VO2) is a function of two major components; the first is cardiac output 
(Q), which is the product of heart rate (HR) and stroke volume (SV). The second component of 
VO2 is arteriovenous difference (A-VO2Diff), which is the amount of oxygen taken up by the 
peripheral tissue expressed by difference between the arterial oxygen content to that of the 
venous oxygen content. 
 Performing a graded exercise test on a treadmill or on a cycle ergometer are two of the 
most common modes of assessing cardiopulmonary function. However the choice of any graded 
exercise test should always depend on the population of which is being tested (Powers and 
Howley, 2012). Graded protocols can either be maximal or submaximal. For maximal tests, 
VO2Max is estimated with equations that allow for the calculation of VO2Max from the last work 
rate achieved on the graded exercise test. During submaximal testing however, VO2Max is 
calculated using heart rate that is plotted against work rate until the termination criteria of the age 
predicted maximal heart rate is reached (Powers and Howley, 2012). There are a vast array of 
testing protocols, maximal and submaximal, in which the progression of the test differs by 
manipulation of the intensity, grade, or speed at a given stage. Below in Table 1. and Table 2. are 
two examples of differing graded exercise testing protocols (Powers and Howley, 2012). 
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Table 1: Standard Balke Protocol For Normal Sedentary Subjects (Balke, 1970) 
Stage METs Speed (mph) % Grade 
1 4.3 3 2.5 
2 5.4 3 5.0 
3 6.4 3 7.5 
4 7.4 3 10.0 
5 8.5 3 12.5 
6 9.5 3 15.0 
7 10.5 3 17.5 
8 11.6 3 20.0 
9 12.9 3 22.5 
*Stages last 2 minutes each. 
 
Table 2: Bruce Protocol For Young Active Subjects (Bruce, 1972) 
Stage METs Speed (mph) % Grade 
1 5.0 1.7 10 
2 7.0 2.5 12 
3 9.5 3.4 14 
4 13.0 4.2 16 
5 16.0 5.0 18 
*Stages last 3 minutes each. 
 
 There are five criteria used for determining whether or not an individual reached VO2Max. 
These criteria include: 1) a plateau or decrease of VO2 with increase in work rate, 2) a blood 
lactate level greater than 8 mmols, 3) a respiratory exchange ratio (RER) of 1.1 or greater, 4) an 
RPE greater than or equal to 17, and lastly 5) a heart rate within 10 beats per minute of the 
predicted maximal heart rate. If three of these criteria are reached then it can be concluded that in 
fact the individual performing the test did achieved his/hers maximal oxygen uptake capacity 
known at VO2Max. If these criteria are not reached instead of deeming it a maximal test, it is 
referred to as a VO2Max test.  
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Reproducibility 
The criteria mentioned above are what exercise physiologists currently use to determine 
whether or not an individual has truly performed a maximal test. However, the accuracy and 
reproducibility of the results obtained during the tests can be affected by many factors and thus 
making it in some occasions difficult to interpret if the test in fact was a true maximal 
cardiopulmonary determination. Factors affecting a test’s reproducibility can be broken down 
into two groups: 1) random error, which includes within-patient biological and temporal 
variations and device/operator/reporter variability, and 2) systematic error, which includes 
phenomena such as familiarization or peripheral fatigue (mainly during cycle ergometer testing 
protocols) which cause results to be very difficult to interpret and use (Shun-Shin, Francis, 2012; 
Barron et al., 2014). Examples of factors that may affect the overall outcome of a 
cardiopulmonary test include encouragement during the test, pre-test conditions in subjects, as 
well as the subject’s familiarity with the equipment. In many cases of test-retest research, to see 
if an intervention has in fact worked with regards to improving aerobic capacity, the 
interpretation of the results are often questioned due to a potential learning effect of the initial 
test in relation to the post test. This issue is believed to be especially augmented in individuals 
who are not familiar with or have never performed this type of test before. Barron and colleagues 
(2014) calls into question this learning affect in his article “Test-retest Repeatability of 
Cardiopulmonary Exercise Test Variables in Patients With Cardiac or Respiratory Disease” 
which concluded that a familiarization effect was observed in a number of variables, with 
persistently better values on the second test. This effect however, was much smaller than in a 
study by Elborn et al. (1990), which showed a 17% increase in peak VO2 from test 1 to 2 in heart 
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failure patients, compared with only 2.5% in Barron et al. study (Barron et al., 2014; Elborn et 
al., 1990). What can be concluded from these two separate studies is that there is a difference 
between test-retest experiments, but to what degree and how large are these differences, is yet to 
be determined. 
In 1989, Cox and colleagues (1989) demonstrated that in patients with obstructive lung 
disease, even though his subjects were not familiar with the cycling test, that there were no 
important learning effects of his test-retest procedure which produced relatively low duplicate 
error. There was no significant difference between the values of the first CPETs performed on a 
cycle ergometer. Reproducibility of the test was deemed good in that workload (4.5%), VO2Max 
(3.5%), RER (3.4%), HR (3.7%), VEMax (6.6%), and VCO2Max (6.0%) were moderately 
reproducible. This indicates that there was no apparent learning effect observed in this patient 
population.  In the same study, Cox and colleagues (1989), healthy control subject’s variability 
from pre to post test was reported at approximately 3% and those with chronic airflow 
obstruction were reported at approximately 6%. In fact, when the subjects of this study were 
asked, 5 of the 11 subjects expected better performance on their second test because of the 
knowledge and experience gained during the first test. However, the study concluded that there 
was no impact on their maximal workload and maximal oxygen uptake, and thus, there seemed 
to be no indication of a learning affect (Cox et al., 1989). In another population with restrictive 
lung disease, Marciniuk and colleagues (1993) demonstrates some of the same concepts and 
concluded that practice exercise studies are not necessary in patients with restrictive lung 
diseases even if they have not previously exercised on a cycle ergometer (Marciniuk et al., 
1993). Therefore, it appears that in patients with cardiopulmonary disease, a practice or 
familiarization session does not seem to affect subsequent tests due to a possible learning effect.  
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Conversely, even with numerous studies indicating no learning effect, the literature is 
unclear. In a similar population, those with chronic airflow limitations, subjects underwent a 
repeated walking test, Knox and coworker found a significant increase in walking distances with 
repeated testing (Knox et al., 1988). Swinburn also found in patients with chronic airflow 
limitations a 29% increase in performance between the first and fourth exercise test on a cycle 
ergometer (Swinburn et al., 1985). Obviously the literature seems to be inconclusive as to 
whether there is or is not a learning effect occurring during many various forms of CPET testing. 
To date, it appears that a learning effect is population specific and more research must be 
conducted to continue to shed light on this potential testing issue.  
Although the evaluation of the learning affect and how it relates to exercise testing has 
been observed in many different populations in literature, mainly those with various lung 
diseases and those with various heart conditions, it has rarely been reproduced in overall healthy 
individuals. A familiarization session is believed to play a crucial role in limiting the learning 
effect that occurs across multiple testing sessions with the same equipment in different 
populations. Without a familiarization session, maximal oxygen uptake recordings could be 
negatively affected and possibly underestimates of the VO2Max of individuals could occur. This 
could have a myriad of negative implications including underreporting of data values in literature 
(which could be the difference between significant and non-significance), low-recorded VO2Max 
values in performance testing, and incorrect exercise prescriptions. A recent study by Wagoner et 
al. demonstrated that there was a significant increase in VO2Max in sedentary middle-aged 
females after 2 weeks of lower body resistance training. The increase in VO2Max was attributed to 
the ability of the subjects to pedal longer via reduced lower limb fatigue resulting from the 2 
weeks of training (Wagoner et. al. 2016). These findings show great applicability to clinical 
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populations in which certain fitness levels may be beneficial in the battling of various etiologies; 
however, a major limitation in Wagoner’s study was the lack of a control group. Without a 
control group one is not able to confirm if the increase in VO2Max was due to the strength training 
or due to the learning effect of the CPET.  
 
Purpose Statement  
The purpose of this study was to evaluate the effects of familiarization on CPET 
performances in sedentary older women, to determine if there is a learning effect and how much 
different this possible learning effect can affect the assessment of cardiopulmonary capacity in 
this population. The reason sedentary older women were the target population in this study was 
because this study was designed to serve as a control group for the aforementioned Wagoner et 
al. (unpublished data). As a result of having no control group, the Wagoner study is subject to 
scrutiny due to a possible learning effect occurring. It could be argued that the subjects did not 
improve physiologically in performing these tests; rather they learned to perform the tests better 
and became more comfortable performing the tests. Another reason that sedentary older women 
were the target population in this current study is that it gives the best representation of how 
healthy individuals may be affected by the learning effect so that it can eventually be studied in 
clinical populations, such as cancer, which ultimately is the population of interest of our 
laboratory. It was hypothesized that there would not be a learning effect between the initial 
CPET and the final CPET. One would believe the values would differ slightly, however these 
differences would not be significant. It was also hypothesized that subjects would exhibit similar 
RER and HR at the same given intensity when comparing post-CPET with pre- CPET.  
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Research Questions  
RQ1. Will VO2Max differ significantly from the pre-test and the post-test? 
RQ2. Will RER differ significantly between pre-test and post-test? 
RQ3. Will the HRMax differ significantly between the pre-test and post-test? 
 
Hypotheses  
H1: Subjects will not exhibit VO2Max values that significantly differ between the first test and the 
last test.  
H2: Subjects will not exhibit significantly different RER scores at any given intensity between 
the first and second CPETs. 
H3: Subjects will not exhibit significant different HRs at any given intensity between the first and 
second CPETs. 
 
Delimitations  
• All subjects were female between 35-65 years of age.  
• All subjects were cleared by a physician prior to participating in the study.  
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Limitations  
• The results of this study may only apply to those whom are women, sedentary, apparently 
healthy and between the ages of 35-65 years old. Results may not be applied to females of all 
ages and males.  
• All subjects were recruited from Chapel Hill, NC and may not a true representation of the 
entire world population. 
• Due to the selected age range and gender, menstrual cycle could affect study results in those 
whom were pre-menopausal.  
 
Significance 
Test-retest reliability is an important factor to consider as it relates to selecting the most 
appropriate and precise testing protocols and instruments in research. The validity of 
cardiopulmonary exercise tests in exercise science studies is important, first and foremost, 
because it determines whether or not an exercise intervention actually had an effect on the 
subject’s oxygen uptake (VO2); where maximum oxygen uptake (VO2Max) has been correlated 
with overall health, longevity, and even prescribed as main intervention in certain populations 
with chronic disease such as cardiovascular disease. Reliability reduces the effects of test-re-test 
limiting factors. Being able to minimize limitations in any testing protocol allows for more 
precise interpretation of the test results and ultimately the efficacy of an intervention. In 
populations where VO2Max values may not be very high such as those with impaired heart and 
lung function as well as cancer populations, a precise evaluation on the “real” effect of an 
exercise intervention can be a difference between improving disease outcomes or even in the 
worst case scenario, death. Regardless of the population in question, the issue of being able to 
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confidently interpret the results of a test, in this particular study a CPET, and being able to 
confidently determine if a learning effect had or not an impact on the results of subsequent tests 
is necessary and paramount if one desires to confidently determine the accuracy of such tests as 
well as using this test as a mean to evaluate an intervention aimed to improve cardiopulmonary 
capacity.   
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CHAPTER II 
 
REVIEW OF LITERATURE 
  
For organizational purposes, Chapter II was organized into five sections: SECTION I. A 
brief overview of maximal oxygen uptake (VO2max) and cardiopulmonary fitness; SECTION II. 
Strength and its role in aerobic capacity; SECTION III. Cardiopulmonary fitness in clinical 
populations; SECTION IV. Cardiopulmonary fitness in healthy populations, and SECTION V. 
Study rationale based on literature/future directions. Results discussed from the articles within 
this section have been selected to provide a history and proper rationale for the study at hand.  
 
 
Overview of Maximal Oxygen Uptake (VO2max) and Cardiopulmonary Fitness 
Maximum oxygen uptake (VO2Max) is defined as the highest rate at which oxygen can be 
taken up and utilized by the body during severe exercise. It represents the integrated capacity of 
the pulmonary, cardiovascular and muscle systems to uptake, transport and utilize O2 (Poole et 
al., 2008). It is one of the main variables in the field of exercise physiology, and is frequently 
used to indicate the cardiorespiratory fitness of an individual. In the scientific literature, an 
increase in VO2Max is the most common method of demonstrating a training effect. In addition, 
VO2Max is frequently used in the development of an exercise prescription. These applications of 
VO
2Max
 are why there has been such great interest in identifying the physiological factors that 
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actually limit VO2Max and in determining the role of this variable in endurance performance 
(Howley and Bassett, 1999). The term “maximal oxygen uptake was define in 1923 by Hill and 
Lupton. They postulated that 1) there is an upper limit to oxygen uptake,   2) there are inter-
individual differences in VO2Max, 3) a high VO2Max is a prerequisite for success in middle-  and 
long-distance running, and 4) that VO2Max is limited by ability of the cardiorespiratory  system 
to transport O2 to the muscles.  Hill and Lupton also stated that, “however much the work rate 
be increased beyond this limit, no further increase in oxygen intake can occur” in reference to 
this upper limit of oxygen uptake (Hill and Lupton, 1923). These postulations demonstrate that 
VO2Max has a physiological limit which is measurable, it is individualized to each person, it can 
somewhat predict success in long distance aerobic evens, and it can be limited due to various 
factors within our body. These postulations beg numerous questions: What specifically causes 
the limit VO2Max? Can this value be reached through some type of intervention, and if so, how? 
Do various diseases or epidemiological problems affect maximal oxygen uptake? Many of the 
questions asked here frankly are the reason as to why VO2Max has not only usefulness in strictly a 
research setting, but even more so in a clinical setting. 
 The measurement of maximal exercise does not necessitate an individual being taken to a 
maximal intensity. This value can be estimated by using a submaximal exercise test. 
Submaximal estimates of VO2Max are based on the linear relationship among heart rate, workload, 
and VO2Max (Morrow et al., 2000). The exercise test requires much less effort than compared to 
those of maximal exercise. One great example of a submaximal exercise protocol is the Astrand-
Rhyming nomogram (Astrand and Rhyming, 1954). It was originally established  as a cycle 
ergometer test that coordinates workload and heart rate responses into a prediction of VO2Max. 
There are also other field methods used to predict VO2Max and aerobic capacity such as distance 
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runs/walks, step tests, the Rockport 1-mile walking test, etc (Morrow et al.). The decision on 
which type of test to use (maximal, submaximal, or field) really depends on the population or 
individual being assessed and what is the safest and most effective way of assessing aerobic 
capacity. 
Maximal testing criteria include: a plateau or decrease in VO2 with an increase in work 
rate, respiratory exchange ratio (RER) (1.00, 1.10 or 1.15); heart rate within 10 bpm or within 
5% of the age-predicted maximum; and blood lactate level of greater than 8–10 mmols. (Poole et 
al., 2008). Poole et al. concludes that utilization of ramp or incremental exercise tests precludes 
achievement of a VO2Max plateau prior to exhaustion in a substantial proportion of individuals. 
Investigators have therefore resorted to a selection of secondary criteria to provide confidence 
that VO2Max has in fact been achieved. This investigation demonstrated that use of established 
secondary criteria of RER, greater than or equal to 1.10 or 1.15, a HRmax within 10 bpm and/or 
a blood lactate greater than or equal to 8 mmols can lead either to a significant under 
measurement of VO2Max or rejection of a large proportion of participants who may actually have 
achieved VO2Max. On the basis of this article it was concluded that these secondary 
measurements might not be as accurate as once believed.  
A comprehensive overview of VO2Max testing and various issues associate with the test 
was investigated by Bassett and Howley in an article titled Limiting Factors for Maximum 
Oxygen Uptake and Determinants of Endurance Performance. This article concluded that 
oxygen delivery, not skeletal muscle oxygen extraction, is the primary limiting factor for VO2Max 
during exercise. This article also points out that metabolic adaptations in skeletal muscle are 
critical for improving endurance performance. Endurance training can actually cause an increase 
in mitochondrial enzyme, thus improving performance by enhancing fat oxidation. Another 
  
14
observation of this article is that it is necessary to decrease lactic acid accumulation at a given 
VO2 , in order to achieve a higher VO2Max. Running economy can also affects endurance 
performance (Bassett and Howley, 2000). All these factors play a role in the determination of 
VO2 and thus play a role in the determination of reproducing this maximal exercise test 
measurements. One factor neglected in a considerable amount of articles discussing VO2Max is 
the role that the learning effect may play in these measurements.  
Strength and Its Role in Aerobic Capacity 
The underestimation of VO2Max discussed by Poole et al., brings about other interesting 
questions. One of which is whether or not other factors may lead to an underestimation of 
VO2Max. It has been debated and shown within literature that sarcopenia may have a negative 
effect on VO2Max. Sarcopenia is the natural loss of muscle mass and strength with age. All 
humans lose muscle mass and function as they age. This is true even of elite athletes who, 
although they continue to be physically active and perform at levels well above those of 
sedentary adults, demonstrate a decline in lean tissue with age. Aerobic capacity declines with 
age in congruence with this loss in muscle mass. This is reflected as both a decline in muscle and 
in cardiopulmonary reserves. Cross-sectional data also show that body cell mass is 
systematically lower in older adults than in middle-aged or young adults (5–7) and so is strength. 
The decline in cell mass with age is largely due to loss of muscle mass (Roubenoff and Hughes, 
2000). Frontera et al., investigated 200 healthy subjects in a cross sectional fashion between the 
ages of 45 and 75, using the isokinetic strength testing of the elbow and knee extensors. The 
results show that a significant component of the age-related muscle weakness is a loss of muscle 
mass (Frontera et al., 1991). This decrease in muscle mass ultimately leads to a decrease in force 
production and can have evident implications when considering aerobic capacity testing 
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completed on a cycle ergometer. Another study by Hartman et al., aimed to determine the effect 
resistance training has on metabolic economy during typical activities of daily living in a 
geriatric population (Mean age = 66). 29 subjects participated in a 26-week heavy resistance-
training program. Before and after the 26-week training intervention, heart rate and expiratory 
gases of each individual were measured while performing 3 tasks that would mimic common 
everyday activities encountered by this population. These tasks included: 1) walking at 3 miles 
per hour, 2) carrying a box to simulate holding a bag of groceries with 1 hand (30% of maximal 
isometric strength) while walking at 2 miles per hour and, 3) climbing stairs. Both strength and 
fat-free mass increased significantly after the training protocol. Oxygen cost decreased 
significantly by 6% for the carrying task whereas the RER decreased significantly for both 
walking and stair climbing. Heart rate decreased significantly for the carrying task. Subjects also 
reported a significant decrease perceived exertion during performance (RPE) of all functional 
task test conditions. This study suggests that a heavy-resistance training program might affect 
exercise economy during daily tasks and improve ease of physical activity. This could be a 
possible mechanism for increasing quality of life in an older/geriatric population (Hartman et al., 
2007). As seen by Frontera and colleagues, the loss of muscle mass between the ages of 45-75 is 
a great contributor to sarcopenia and muscle weakness as one progresses in age. Hartman et al. 
then shows that heavy resistance training may improve some aspects of everyday activities in an 
older population. This leads to the rationalization that it may be possible that heavy resistance 
training can also attenuate some age related affects of sarcopenia as well in a middle-aged 
population.  
These increases in muscle mass or attenuation of muscle mass loss may have direct 
implications to VO2Max testing performance. If there is more muscle mass present for an 
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individual to recruit during exercise, then more force can be exerted by that individual during the 
exercise task at hand. This may especially true in an activity such as cycle ergometry, where the 
resistance within the bike pedals continually increases and necessitates more force to turn the 
pedals as stages progress. Being able to produce extra force may allow an individual to go to a 
higher stage during a maximal exercise protocol and thus achieve and higher VO2Max values. Fleg 
and Lakatta investigate this very problem in, The Role of Muscle Loss in the Age-Associated 
Reduction in VO2Max. Specifically they investigated to what extent the decline in VO2Max could be 
attributable to the age associated loss of metabolically active tissue, such as sarcopenia. In order 
to achieve this, creatinine excretion, an index of muscle mass, was measured in 184 non-obese 
individuals between the ages of 22 and 87 who performed a true VO2Max during a graded exercise 
protocol. A positive correlation was found between VO2Max and creatinine excretion in men as 
well as in women. VO2Max also showed a strong negative linear relationship with age in men and 
women as well, which is expected. VO2Max was normalized for creatinine excretion and 
expressed per milligram of creatinine excretion rather than in the customary fashion. When this 
was done only 14% of the decline in aerobic capacity was explicable by age compared to that of 
60% when solely VO2Max and age were compared in men. In women there were similar numbers, 
as the aerobic capacity explicable by age decreased from 50% to only 8%. In comparing the 
standard age regression of VO2Max per kg body weight with that in which VO2Max was normalized 
per mg creatinine excretion, the decline in VO2Max between hypothetical 30 year old and 70 year 
old was reduce from 39% to 18% in mean and from 30% to 14% in women. Essentially this 
means that a large portion of the age-associated decline in VO2Max in non-endurance trained 
individuals can be attributable to loss in muscle mass (Fleg and Lakatta, 1988). 
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Cardiopulmonary Fitness in Clinical Populations 
 Exercise testing is an important tool that can be used for early diagnosis of lung function 
decrements as well as determining treatment effectiveness in clinical populations where there 
may be impaired lung function. In 1989, Cox et al. designed a study to examine the 
reproducibility and the learning effect of an incremental exercise testing. Specifically, Cox and 
colleagues studied cycle ergometer testing in patients with obstructive lung disease who were 
untrained, and who also had never done such a test prior to this study. This study examined 11 
total patients with obstructive lung disease and was designed in a test retest fashion, as the 
subjects performed the first test then the second test 24 hours after. This study found that there 
were no significant differences between values of the first and second testing procedure. This 
indicates that there was in fact no learning effect that occurred during this cycle ergometer test. 
Results indicated good reproducibility for workload (4.5%), VO2max (3.5%), RER (3.4%), and 
HR (3.7%) (Cox et al., 1989). These results indicate that despite subject not being familiar with 
the test and testing protocol, there were not major learning effects between the two testing 
procedures in each subject. 
In 1993, Marciniuk, Watts, and Gallagher also examined reproducibility of variables 
measured during exercise testing in subjects with stable restrictive lung disease. 6 subjects were 
used for this study, all of which had also never performed an exercise test of this capacity. These 
subjects underwent a total of 3 exercise testing protocols on an electrically braked bike, which 
spanned over 28 total days, with each test separated by at least 7 days. Variables of interest were 
measured at the beginning of exercise, 40% of the maximum work rate, 70% of the maximum 
work, and at the end of exercise. The results of this study show that there was no significant 
difference in exercise duration, work rate, or the peak VO2 at end of exercise among the three 
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exercise sessions. VCO2, W, VT, f, SaO2, HR, and Borg scores also did not differ among the 
three studies at end of exercise. Interestingly, there was also no significant difference in these 
variables at 40% Wmax and 70% Wmax. Comparison of these results, measured at 40% Wmax and 
70% Wmax, show that reproducibility at submaximal levels of exercise parallels the 
reproducibility of measurements made at end of exercise (Marciniuk, Watts, and Gallagher, 
1993). This suggests that, in addition to generating reproducible end of exercise measurements, 
measurements made at submaximal levels of exercise may also be used in evaluating the results 
of clinical exercise testing in these types of patients with lung impairment.  
However, not all of the literature supports the notion that there is no learning effect in this 
particular population. Knox et al. reports in his study the “Reproducibility of Walking Test 
Results in Chronic Obstructive Airways Disease”, that there is in fact a learning effect that 
occurs during cardiopulmonary fitness assessments. The study looked at 12 patients over 3 
consecutive days with 4 separate 5 minute walking distances per day with visual cues. The other 
group used in the study consisted of 24 subjects who performed 3 walks per week (on the same 
day) over 4 consecutive weeks. This study concluded that a learning effect was in fact evident, 
especially when walking tests were carried out over short time intervals. This study also 
collected data that shows that this learning effect may persist for up to 9 walking tests. When the 
walking tests were carried out over consecutive weeks rather than carried out over a shorter time 
interval, the learning effects were found to be less pronounced. Knox et al. recommends that, 
specifically with walking tests, that a minimum of 5 practice walking sessions should be used in 
order to familiarize the individual with the procedure when walking tests are performed over 
consecutive days. As for tests performed over consecutive weeks, the study recommends a 
minimum of 4 walking familiarization sessions to allow for the most accurate measurement of 
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fitness level. Another study by Swinburn et al., Performance, Ventilation, and Oxygen 
Consumption in Three Different Types of Exercise Test in Patients With Chronic Obstructive 
Lung Disease show a similar learning effect when it comes to repeat testing of cardiopulmonary 
capacity. In this study subjects performed a 12-minute walking test, a paced step test, as well as a 
cycle ergometer test. This study found that there was a progressive and significant increase in 
performance in all three types of exercise test between the first and fourth measurements 
(analysis of variance p < 0.01). The overall increases in performance were: steps climbed 96%, 
duration of cycle exercise 29%, and 12 MWD 16%. Swinburn concludes that an important 
observation is the continuing improvement in exercise performance clearly seen in all three types 
of test with repeated testing. This is unlikely to have been due to physical training over such a 
short period, but it was not surprising in symptom limited tests such as these because increasing 
familiarity with the tests may have led to an increase in confidence and therefore motivation 
(Swinburn, 1985). An important note from this study is that the walking test had the lowest 
percent increases and seems to be the most reproducible between these 3 tests. In most cases, 
some form of walking is completed each day by individuals and is a familiar task to most people. 
A step test or a cycle ergometer may however not be as familiar to the average individual. 
These results and conclusions of Knox and colleagues and Swinburn and collegues show 
that in clinically compromised populations there does seem to be a learning effect occurring. 
However, Cox and colleagues and Marciniuk, Watts, and Gallagher show that there is not a 
significantly large difference between specific variables associate with cardiopulmonary exercise 
testing. Given the nature of this clinical population and the fact that many individuals have never 
taken part in a graded cardiopulmonary exercise test, a learning effect could very well be 
occurring in this subset of the population. This data only supports the necessity for a 
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familiarization session when testing subjects with an exercise test that may not be familiar to 
them. 
 In 2014, Barron et al. investigated the different measures of test-retest reliability in 
patients with cardiac and respiratory disease. A familiarization effect was observed, however it 
was much smaller than had been previously reported. This study looked at a myriad of 
cardiorespiratory variables. Out of the myriad the variables observed, Peak VO2, anaerobic 
threshold (AT), peak heart rate (HR), double product (DP), peak minute ventilation and 
respiratory frequency, and peak work rate showed significant positive differences between tests 1 
and 2.  Only a 2.5% increase was seen in this study between test 1 and test 2 compared to another 
study by Elborn et al. that saw as much as a 17% increase in VO2Max in heart failure patients 
(Barron et al., 2014). One key difference to note here between the two tests however is the use of 
a treadmill in the Elborn study versus the use of a cycle ergometer in Barron’s study. Barron 
concludes that the majority of variables calculated in this study from cardiopulmonary exercise 
testing shows excellent test–retest reliability. Peak VO2, OUES, O2 pulse, peak circulatory 
power, and the VE/VCO2 ratio at nadir show excellent test–retest reliability. Measures of the 
anaerobic threshold and the VE/VCO2 slope show good test–retest reliability.  
 Elborn et al., an aforementioned study, also assessed whether or not there was a learning 
effect that occurred in cardiopulmonary exercise testing in cardiac compromised patients. The 
purpose of this study was to evaluate the reproducibility of peak VO2, exercise time and other 
cardiopulmonary parameters during repeated treadmill exercise testing in patients with moderate 
to severe chronic cardiac failure patients (Elborn et al., 1990). 30 total subjects with cardiac 
function impairment performed 3 cardiopulmonary exercise tests with at least 2 weeks of 
separation between each test. Changes over the three tests at rest, at a submaximal intensity, and 
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at maximal intensity were analyzed. There were no significant changes in resting parameters 
over the three tests. Exercise time and the stage during which the test was terminated both 
significantly increased between tests 1 and 2.  No difference was observed between tests 2 and 3, 
during which the values were again significantly greater than test 1. At maximal exercise, there 
was no significant difference in heart rate, systolic blood pressure or respiratory rate responses. 
There was a significant increase in VO2 as was peak VE. There was no significant change in 
perceived exertion score at maximum exercise. This study by Elborn shows that all the 
parameters measured during a cardiopulmonary exercise test at rest and during symptom-limited 
exercise were reproducible between the second and third test. However, the first exposure of 
patients with chronic cardiac failure to an exercise test such as this resulted in an underestimate 
of exercise time by about 20%. Patients also achieved a higher exercise stage in test 2, despite 
their perceived exertion being similar. Peak exercise VO2, VCO2 and VE were also significantly 
underestimated between the first and second test. Elborn postulates that there may be several 
factors that to the observed improvement in exercise performance between tests 1 and 2. The first 
explanation is that the patient becomes familiar with the technique of treadmill walking and 
adapts to the awkward breathing via a respiratory valve with the nose clipped. As this process is 
unnatural and somewhat uncomfortable, becoming more comfortable with this type of breathing 
after repeated tests seems logical. The initial fear is overcome, and confidence develops. Another 
explanation is a physical training effect, but because the tests were all at least 2 weeks apart, this 
seems unlikely. Since therapy and symptom status were unchanged, an improvement in cardiac 
function was also unlikely to have been a factor. Another important result of this study to 
observe is that an improvement between tests 1 and 2 was also observed at submaximal exercise 
levels, although the heart rate and blood pressure responses were similar. This indicates that 
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overall exercise performance was improved. These changes from the first test to that of the 
second test, not only in the respiratory/lung populations, but also here in populations with cardiac 
issues necessitates the need for that first exercise session to familiarize the patient with the 
testing procedures as well as the testing protocol to efficiently eliminate any discrepancies that 
may occur due to a learning effect. 
 
Cardiopulmonary Fitness in Healthy Populations 
 This learning effect phenomenon has also been studied to some degree in healthy subjects 
as well as elite athletes. One such example of this can be seen in Reproducibility of Incremental 
Maximal Cycle Ergometer Tests in Healthy Recreationally Active Subjects (Dideriksen et al., 
2015). This study used a population of recreationally active triathletes who performed an average 
of 3 hours of endurance exercise per week for the last year. One particularly important note 
about this study is that none of the subjects had previously performed an incremental cycle 
ergometer test, however some were familiar with stationary bike riding. The 13 subjects in this 
study performed 3 identical cycle ergometer maximal exercise tests to determine VO2Max. 
Because the study aimed to investigate whether a learning effect could be observed, no 
physiological familiarization to the experimental procedures or equipment were allowed. Instead, 
the subjects were simply carefully informed about the experimental procedures the day of the 
first test. The 3 tests were all separated by at least 48 hours as well. Coefficient of variation 
percentages and intraclass correlations were used to determine the reproducibility of VO2Max and 
how time averaging intervals affected this value. This study concluded that there is high 
reproducibility of VO2Max measures was obtained regardless of time-averaging interval (5–60 s), 
and no learning effect was observed. However, the absolute level of VO2Max was higher using 
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shorter time-averaging intervals compared with longer.  
 Fielding et al. (1997) also investigated the reproducibility of VO2Max exercises tests in 
healthy individuals, specifically in older women. 17 women were used for this study from 51 to 
68 years old. Each subject performed 5 different exercise tests separated by at least 1 week’s 
time. Subjects performed the Modified Bruce protocol on a motor driven treadmill. The protocol 
was as follows: with the following 3-min stages: Stage I (2 mph, 10% grade), Stage II (2.5 mph, 
12% grade), Stage III (3.4 mph, 14% grade), and Stage IV (4.2 mph, 16%). Oxygen uptake was 
measured continuously and metabolic data was taken every 30 seconds. Differences between 
each test were determined using an ANOVA. Pearson's correlation coefficient was also used to 
determine agreement between tests. Reliability estimates for each variable were also calculated 
using intraclass correlation coefficients. VO2Max values were found to be consistent between all 
tests, with the mean coefficient of variation being 6.5%. Mean maximal ventilation was also not 
significantly different between tests. RER and maximal HR reached between tests was also not 
significant. A Person product correlation was also used to determine the agreement between the 
tests. For each given measurement there were significantly high levels of agreement between 
tests with r values ranging from 0.70-0.89. In addition, intraclass correlation coefficients for a 
single test are high and suggest good agreement between tests. In general, the associations did 
improve between test 2, test 3 and test 4. This study concluded that the Bruce treadmill protocol 
for women who are older (51-68 years old) produces highly reproducible results with VO2Max, 
maximum heart rate, as well as ventilation. It is suggested that performance of only a single 
VO2Max  test is sufficient to assess aerobic capacity in middle-aged and older women.  
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Study Rationale Based on Literature/Future Directions 
 Given the above literature, it is logical as to why the testing of middle-aged sedentary 
older women is important. It is necessary to determine the reproducibility of VO2Max exercise 
tests in this population with hopes that future studies that use this test measurement in an attempt 
to quantify aerobic capacity can be precisely interpreted. While testing of healthy subjects 
generally seems to be in agreement with each other, specific clinical populations such as lung 
and heart diseased patients is not so clear. Determining the reproducibility of this test has 
numerous ramifications in research and the clinical setting. First, it would decrease the number 
of tests necessary to be sure that a precise measurement of VO2 value was obtained. Many times 
a familiarization session (or multiple) is needed to mitigate learning affect that may be present in 
a test-retest situation. In clinical populations where such things as sitting up or walking are 
difficult, this does not seem feasible. Another issue associate with this reproducibility is the 
accuracy of values reported within literature. Underestimation of VO2 was clearly demonstrated 
in the aforementioned study by Poole et al. (2008) and could lead to misrepresentation of data 
within literature as well as incorrect aerobic capacity assessments for athletes and clinical 
populations. The choice of sedentary older women was purposeful in nature in that this group 
was selected due to the age range and activity style and most likely be experiencing sarcopenia, 
which somewhat is similar to women who have been diagnosed with breast cancer. It is our 
intent to reproduce this study in women diagnosed with breast cancer so to be able to better 
understand the potential importance to conduct or not a familiarization session with these women 
to maximize the accuracy of the test and therefore better interpret the effects of exercise 
intervention in this cancer population. To be clear, the evidence found in this study is not directly 
generalizable to the breast cancer population, but knowledge obtained about sedentary middle 
  
25
aged women will hopefully provide the rationale to further explore the findings in a similar 
population of women with similar age who have been diagnosed with breast cancer. Few studies 
have investigated this phenomenon in middle-aged women of in any cancer population; therefore 
it would add to the wealth of knowledge in the field of exercise as it relates to assessment of 
cardiopulmonary capacity.  
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CHAPTER III 
 
METHODOLOGY  
Subjects 
Recruitment for the study was completely voluntary, as subjects were made aware of the 
study via flyers, emails, phone calls, as well as face-to-face interaction with research team 
members. Recruitment sites included areas that fell within that of Chapel Hill, North Carolina. 
Approval from the Institutional Review Boards in Exercise and Sport Science and School of 
Medicine at UNC-Chapel Hill were obtained from all subjects before participating in any aspect 
of the study. 
 All subjects participating in the study were between 35 to 65 years of age and sedentary. 
The sedentary nature of the participants was defined by not having participated in regularly 
scheduled exercise more than once a week for at least 6 months prior to beginning the study. 
Subjects were enrolled in the study if they present no cardiopulmonary and musculoskeletal 
disease that would preclude their participation in any aspect of the study as determined by a 
physician physical evaluation prior to any testing. Subjects were screened for exclusion based 
upon the criteria presented by the American College of Sports Medicine (ACSM) as 
contraindications to exercise testing (Pescatello & American College of Sports, 2014).  
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Study Overview 
 This study was designed to collect data in a group of Sedentary Middle-Aged Females 
following a similar protocol of an unpublished Master’s Thesis completed at UNC Chapel Hill 
titled, The Effect of a Two-Week Lower Body Resistance Training Protocol on Aerobic Capacity 
(VO2Peak) in Sedentary Middle-Aged Females (Wagoner et. al. 2016). The difference between 
Wagoner et al. study and the current study was that the group of Sedentary Middle-Aged 
Females that were recruited to participate in the current study did not undergo an exercise 
intervention as subjects did in the Wagoner et al. 2016 study. In Wagoner et al. 2016 study, the 
researchers employed a two-week resistance training exercise intervention aimed to provide 
subjects a better muscular activation capacity believed to allow for the subjects improve their 
performance in a post CPET administered just two weeks after the pre CPET. Since Wagoner et 
al. study did not have a control group; the current study was designed to examine the issue 
associated with a potential learning effect that could have potentially confounded Wagoner et al. 
study where the improvements observed in VO2Max may or may not have been attributed to the 
training and perhaps to the learning effects of testing.  
The study procedures, parameters, and equipment used in Wagoner et al. study were 
exactly the same as the study design and procedures of this current study with the exclusion of a 
1 rep maximum (1RM) tests, that were performed in Wagoner et al. with the goal of informing 
the training loads for the study intervention and the exercise intervention itself. 
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Figure 1 below is a graphic representation of the study events.  
 
Figure 1. Study Timeline 
 
 
      1 Week 
    →      
    
  
  
     
Instrumentation 
Anthropometric / Screening   
 Height was measured to the nearest 0.1 cm via a portable stadiometer (Perspective 
Enterprises, Portage, MI USA), and mass measured to the nearest 0.1 kg via a mechanical scale 
(Detecto, Webb City, MO USA).  
A medical history questionnaire (Department of Exercise and Sports Science) was used to 
log the subjects’ medical history, age, race, and relative physical activity level within the past 
year. This was utilized in conjunction with the physical examination and resting 
electrocardiogram (EKG) in determination of subject safety to participate in the study. The 
resting EKG was conducted using a GE CASE Cardiosoft V. 6.6 ECG diagnostic system 
(General Electric, Palatine, IL USA). Additionally, resting blood pressure was measured 
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→ 
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manually via a Diagnostix 700 aneroid sphygmomanometer (American Diagnostics Corporation, 
Hauppauge, NY USA) and a Litmann stethoscope (3m, St. Paul, MN USA). 
 
 
Cardiopulmonary Test (CPET)  
 
VO2Max was assessed using a Parvo Medics TrueMax 2400 Metabolic System (Parvo 
Medics, Salt Lake City, UT USA) on a Lode electronically braked cycle ergometer (Lode, 
Gronigen, The Netherlands). The subjects’ respiratory responses were obtained by the use of a 
Hans Rudolph 7450 Series V2 Respiratory Valve (Hans Rudolph Inc., Shawnee, KS, USA). Rate 
of perceived exertion (RPE) was assessed using a Borg 6-20 Rate of Perceived Exertion (RPE) 
scale. Heart rate was monitored via a Pacer Polar heart rate monitor (Polar Electro Inc., Lake 
Success, NY USA). Post CEPT lactate measurement was obtained 3 minutes post completion of 
the CPET using a portable lactate analyzer (Lactate Plus, Sports Resource Group, Hawthorne, 
NY).  
   
Procedures   
All subjects reported to the Exercise Oncology Research Laboratory (EORL) and the 
Neuromuscular Research Laboratory (NMRL) on a total of three separate occasions related to 
familiarization and testing purposes. The first visit included a familiarization and the initial 
ultrasound (US) measurements. The second visit included a pre-testing session. The last visit 
included the post-testing session and another US measurement. Before reporting for testing 
sessions, subjects were asked to follow a set of pre-assessment guidelines and were questioned as 
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to if they in fact followed the guidelines upon arriving to the lab. These guidelines included 
maintaining a proper hydration status as assessed by an American Optical, Hand Held TS Meter 
(Keene, New Hampshire, USA) refractometer, being at least two hours fasted, no caffeine 
consumption at least eight hours prior, and no alcohol consumption at least twenty-four hours 
prior. All subjects within the study were required to undergo a physical screening and approval 
by a physician in accordance with a 12-lead EKG, medical history questionnaire, and PAR-Q 
form. All visits took place in the EORL and NMRL.  
 
Visit One: Physical Screening, Ultrasound, and Familiarization of Testing Procedures 
 The first visit to the laboratory included signing of the informed consent form, 
completion of the medical history questionnaire, PAR-Q, and a 12-lead resting EKG as part of a 
physical examination by a physician member of the research team. Height and weight were also 
obtained during visit one. 
 
Ultrasound  
 For the US assessment, subjects laid supine for ten minutes on a table to allow for fluid 
shifts with their right lower limb in a relaxed position at full extension. Scanning sites for the 
CSA of the VL were determined by taking half the femur length as obtained by measuring the 
full length from the greater trochanter to the lateral condyle using a Gulick tape measure 
(AliMed, Dedham, MA, USA) (Mangine et al., 2014). US transmission gel was then applied to 
the subject’s skin and probe in order to enhance signal with the US imaging device. A probe 
support was used to ensure that the probe scans were perpendicular to the VL along the 
transverse axis (lateral to medial). Three consecutive panoramic scans of the VL at a gain of 
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50dB and a depth of 5.0 cm (Mangine et al., 2014) were taken in order to assess CSA. The 
greatest CSA value obtained from the 3 separate scans was used for data analysis. 
 
 
 
Familiarization: Isokinetic EMG Strength Testing  
Subjects were familiarized with the testing protocols so they were accustomed and 
comfortable with the entirety of testing procedures.  Initially, subjects were taken to the NMRL 
to be familiarized with the isokinetic EMG assessment. For the EMG familiarization, subjects 
were asked to sit in the dynamometer chair, and a member of the research team adjusted all 
harnesses to replicate the actual testing session. Subjects were then instructed on the isokinetic 
leg extensions simulating exactly the procedure that subject would then be undergoing during the 
day of testing. Once procedures have been discussed, subjects performed three consecutive 
isokinetic leg extensions at 50%, 60% and 75% of their perceived maximal effort. Velocity of 
the isokinetic leg extension was set at 60° per second.   
 
Familiarization: Cardiopulmonary Testing  
Subjects were then familiarized with the cardiopulmonary exercise test (CPET) on a 
cycle ergometer.  Subjects were fitted for a respiratory mask and seat height on the cycle 
ergometer was adjusted and recorded for proper cycling pedaling mechanics. Subjects wore a HR 
monitor and were given time to become accustomed to the mask and cycle ergometer. Subjects 
then preceded with a simulation of the test protocol to be used during the test day up to the point 
of 75% their target heart rate (THR), which was determined by the heart rate reserve method.  
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Visit Two (Pre) and Three (Post): Testing Sessions 
 The pre and post visits have been combined in this section since the procedures for both 
sessions with exception of an US measurement, that was also taken on visit 3, were identical. 
Testing procedures occurred in this order: (1) Isokinetic EMG strength testing and (2) the 
VO2Max assessment. A rest period of a minimum of 10 minutes and a maximum of 15 minutes 
was utilized between the two tests and rehydration allowed in order to ensure proper recovery.   
 
Isokinetic EMG Strength Testing  
 Isokinetic EMG strength testing was used in order to determine if there were any strength 
associated changes between the pre-test and the post-test, and to follow exactly the protocol 
employed by Wagoner et al. 2016. Prior to beginning the strength test, subjects warmed up on 
the cycle ergometer for 5 minutes at 50 Watts. Subjects were then taken to the NMRL for the 
isokinetic leg extension EMG assessment. Procedures were based off those conducted by 
previous studies in similar populations (Bottaro, Russo, & de Oliveira, 2005; Theou, Gareth, & 
Brown, 2008). Subjects were then placed in the dynamometer chair with harnesses placed over 
the shoulders, waist, and right leg. The right knee was aligned with the dynamometer’s center of 
axis of rotation at 90° as measured by a goniometer (Model G800, Whitehall Manufacturing, 
Industry, CA, USA). EMG surface electrodes were then placed on the muscle belly of the VL. 
The location of the muscle belly was determined as 66% of the femur length. EMG electrodes 
were placed parallel to the muscle fibers of the VL. Once electrodes were in position, subjects 
were instructed to complete three warm-up isokinetic leg extensions at 50%, 60%, as well as 
75% of their perceived maximal effort at a velocity of 60° per second. Subjects proceed to 
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complete three maximal isokinetic leg extensions at a velocity of 60° per second with two 
minutes of rest between each contraction. The greatest peak torque value recorded between the 3 
contractions was used for data analysis, as the subsequent EMG amplitude. 
 Subjects then completed one maximal isometric contraction at a set knee angle of 120° 
(60° below horizontal) for purposes of normalizing EMG amplitude. Members of the research 
team provided verbal encouragement during each contraction. The highest PT and peak 
amplitude (PA) values of the three contractions were used for data analysis.   
 Signal processing was accomplished via a Biopac MP150WSW data acquisition system 
and AcqKnowledge software (Biopac Systems, Inc., Santa Barbara, CA, USA) recorded EMG 
signal. Raw PA and PT signal was stored on a personal laptop computer (MacBook Pro, Apple 
Inc., Cupertino, CA, USA) and analyzed with Labview 2014 software (Version 14, National 
Instruments, Austin, TX, USA).  
 
Cardiopulmonary Fitness Assessment 
 The final assessment was the cardiopulmonary exercise test for the assessment of 
VO2Max.  The test was performed on an electronically braked cycle ergometer using the Astrand 
Cycle Ergometer Maximal Test Protocol. Subjects began the test by sitting quietly on the cycle 
ergometer for three minutes while the researchers collected resting metabolic data. The first stage 
of the test was set to begin at 0 watts and lasted for three minutes. The preceding stage also 
lasted three minutes with an increase to 50 watts. Each of the subsequent stages increased by 25 
watts until subjects reached volitional exhaustion. HR, RER, and RPE (6-20) were continually 
monitored and recorded during the last 30 seconds of every stage. Termination of the test was 
determined by the subjects’ reaching volitional exhaustion and signaling to stop the test, VO2 
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plateau or decrease with increase in exercise intensity, or if an abnormal subject response to the 
test was observed. Upon the test being terminated, subjects were escorted to sit comfortably in a 
chair and after 3 minutes of rest, a finger prick was used to collect a drop of blood for lactate 
evaluation. Criteria established for VO2Max set forth by the American College of Sports Medicine 
(ACSM) was used to determined if the test of maximal or peak. 
 
 
Data Analysis 
 Collected data for this current study was analyzed with SPSS Statistics version 23.0. The 
alpha level was set a priori for all statistical analyses at 0.05. Descriptive statistics of the 
population characteristics such as age, height, body mass, was presented in the form of mean and 
standard deviation. Paired samples t-tests, used to compare the results of the CPETs, were 
conducted for a pre-test and post-test (period of 2-weeks with no exercise intervention) for the 
following variables: VO2Max, RPE, HR. Exploratory evaluations on PT, peak EMG amplitude, 
and CSA were also conducted using paired samples t-tests.  
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CHAPTER IV 
  
RESULTS 
 
 The purpose of this study was to evaluate the effects of familiarization on CPET 
performances in sedentary middle-aged women, to verify whether or not there is a learning effect 
and how much this possible learning effect can affect the assessment of cardiopulmonary 
capacity in this population. More specifically, the research questions being addressed were: Will 
VO2Max differ significantly from the pre-test and the post-test (RQ1), will RER differ 
significantly between pre-test and post-test (RQ2), and will the HRMax differ significantly 
between the pre-test and post-test (RQ3)?  
 
Subjects  
 The study included a total of 6 sedentary middle aged females. Subject characteristics are 
presented as means + standard deviations in Table 3 below. Subject characteristics appear similar 
to those in the afformentioned Wagoner et al. study with neither group being significantly 
different from the other in each of the characteristics other than in weights (Wagoner’s study: Pre 
weight: 78.0 ± 17.2; Post Weight: 77.7 ± 17.0). Only 5 subjects data were used to assess peak 
torque and EMG amplitude from pre to post intervention, as one subject’s pre-test file was 
excluded due to a sampling error. The subjects’ characteristics are presented in Table 3 below: 
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Table 3: Subject Characteristics; n = 6 (mean + SD) 
Age (years) 53 ± 7 
Height (cm) 160.3 ± 6.0 
Pre-Weight (kg) 73.4 ± 16.7 
Post-Weight (kg) 73.9 ± 16.6 
BMI (kg*m-2) 28.90 ± 7.67 
 
Post Menopausal (# of participants) 5 
 
 
Hypothesis Analysis 
Out of the 6 subjects included in the analyses, 5/6 achieved VO2Max during the pre-test 
session by complying with the VO2Max criteria determination adopted by the current study as 
given forth by ACSM. For the post-test, the results are different; only 4/6 participants achieved 
VO2Max according to the criteria determination adopted here. Below in table 4, pre and post 
means, standard deviations, of all primary variables, including Respiratory Exchange Ratio and 
Lactate values collected 3 minutes post completion of the CPET are presented for each subject 
below. It should also be noted here that subject 5 was experiencing illness during the post-test 
session and this may have affected her testing values. 
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Table 4: CPET Variables by Subject (Mean ± Standard Deviation) 
* p < 0.05 from pre to post intervention  
Hypothesis 1, that subjects would not exhibit VO2Maxvalues that significantly differ 
between the pre-test and post-test, was evaluated using paired samples T-tests. Significant 
decreases in both, relative VO2Max [ml/kg/min], p=0.03 (-9.68%) and absolute VO2Max [L/min], 
p=0.03 (-9.33 %) were observed. Hypotheses 2 and 3, subjects will not exhibit significantly 
different RER scores at the final stage of the CPET between the pre and post CPETs and subjects 
will not exhibit significant different HRMax were analyzed using paired samples T-tests. No 
significant differences in RER, p=0.27 (-2.61%) or HRMax, p=0.29 (-3.13%) were observed. 
 
 
Exploratory Analyses 
Paired T-tests were used to asses the strength variables peak torque, EMG amplitude, and 
CSA data is presented in table 5. In addition, the mean percent change is reported in the 
following sentence. None of these variables were found to be significantly different from pre to 
post test; peak torque, p=0.546 (-7.15%), EMG amplitude, p=0.817 (+1.98%), and CSA p=0.704 
(+1.56%). 
 
 
Subjec
t 
Rel. VO2Max 
mL *kg-1 * 
min -Pre 
Rel. VO2Max  
mL *kg-1 * 
min - 
Post 
Abs. 
VO2Max  
L *min-1 
Pre 
Abs. 
VO2Max  
L *min-1 
Post 
RER Last 
Stage  
Pre 
RER Last 
Stage 
Post 
HRMax  
BPM 
Pre 
HRMax  
BPM 
Post 
RPEMa
x  
Score 
Pre 
RPEM
ax 
Score 
 Post 
Lactate  
mmol 
Pre 
Lactate  
mmol 
Post 
1 16.87 15.90 1.16 1.10 1.13 1.09 133 132 17 17 5.2 4.8 
2 27.13 25.27 1.75 1.63 1.08 1.14 172 177 19 18 6.7 7.9 
3 38.33 34.67 2.63 2.37 1.16 1.15 162 166 17 19 9.4 8.6 
4 17.57 17.43 1.86 1.85 1.19 1.16 167 166 18 19 9.3 10.2 
5 35.40 28.47 2.10 1.69 1.15 1.08 150 126 17 14 9.2 5.0 
6 30.43 25.70 2.26 1.94 1.16 1.08 177 160 20 18 6.4 5.5 
Mean 
± SD 27.62 ± 8.95 
24.57 ± 
7.00* 1.96 ± 0.50 
1.76 ± 
0.42* 
1.15 ± 
0.04 
1.12 ± 
0.04 
160 ± 
16 
155 ± 
21 
18 ± 
1.26 
17.50 
± 
1.87 
7.7 ± 
1.8 7.0 ±2.2 
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Table 5: Exploratory Strength Variables by Subject (Mean ± Standard Deviation) 
Subject 
PT Pre 
(N*m) 
PT Post 
(N*m) 
EMG Amp. Pre 
(mV) 
EMG Amp. Post 
(mV) 
CSA Pre 
(cm2) 
CSA Post 
(cm2) 
1 N/A N/A N/A N/A 14.26 14.67 
2 63.86 71.93 121.27 121.59 10.46 12.48 
3 95.03 113.74 111.26 138.96 13.12 13.25 
4 49.84 33.81 43.43 39.09 14.28 15.41 
5 85.46 79.60 99.92 81.98 15.23 13.27 
6 125.57 89.11 88.31 91.76 17.31 16.92 
Mean ± SD 83.95 ± 29.26 77.64 ± 29.12 92.84 ± 30.25 94.68 ± 38.55 14.11 ± 2.27 14.33 ± 1.66 
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CHAPTER V 
 
DISCUSSION 
Overview 
The purpose of this study was to evaluate the effects of familiarization on CPET 
performances in sedentary middle-aged women, to verify whether or not there is a learning 
effect. Previous literature has been inconclusive as to whether or not a learning effect can 
influence during CPET performance. Cox et al. and Marciniuk et al. have shown in clinical 
populations that reproducibility of these cardiopulmonary exercise tests are adequate, even at 
submaximal levels (Cox et al., 1989; Marciniuk, Watts, and Gallagher, 1993). However, not all 
studies have shown high reproducibility of cardiopulmonary exercise testing, suggesting there 
may in fact be an observed learning effect. Knox et al. (1988) concluded that a learning effect 
was in fact evident in patients with chronic airway obstructions, during walking tests when they 
were carried out over short time intervals (4 walking tests for 3 consecutive days; 12 total tests). 
This study shows the importance of familiarizing individuals with the testing procedures in order 
to mitigate this learning effect and inaccurately reported fitness values (Knox et al., 1988). 
Swindburn et al. (1985) also reports a learning effect in multiple tests of aerobic capacity in 
patients with chronic airway obstruction disease. In this study, subjects performed a 12-minute 
walking test, a paced step test, as well as a cycle ergometer test. This study found that there was 
a progressive and significant increase in performance in all three types of exercise test 
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(Swindburn et al., 1985). The learning effect is an important factor to consider as it relates to 
selecting the most appropriate and precise testing protocols and instruments in research. The 
validity of cardiopulmonary exercise tests in exercise science studies is obviously important in 
that it determines whether or not an exercise intervention actually had an effect on the subject’s 
oxygen uptake (VO2) such as in the Wagoner et al. study. Recall that this study determined 
whether or not a 2-week lower body resistance protocol was enough to increase VO2Max values in 
sedentary middle-aged women. The issue lies in being able to confidently interpret the results of 
a CPET and being able to effectively determine if a learning effect had an impact on the results 
of subsequent tests is necessary. Especially in clinical populations, placing these populations 
through as little stress as possible while still obtaining an accurate interpretation of the testing 
results is paramount if one desires to confidently determine and report the accuracy of such tests.  
 
Aerobic Capacity 
Significant decreases in maximum oxygen uptake values from pre to post-test were 
observed, which was contrary to our hypothesis.  These findings may be attributed to a multiple 
factors including, but not limited to, a diminished knowledge of the test during the 2 weeks 
between pre and post intervention (which may have been masked in the Wagoner et al. study due 
to subsequent increases in strength) , a really well performed familiarization session between 
visit 1 and visit 2, or potentially a loss of motivation. These concepts will be discussed in further 
detail below. 
To our knowledge, no other study observed showed a significant decrease in aerobic 
capacity from pre to post test. While some studies have showed decreased VO2 values, these are 
usually in clinical populations in which no exercises has been assigned or with long time spans 
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with regards to the testing windows. Previous studies were inconclusive when it comes to 
determining whether or not a learning effect occurred. Previous studies without any exercise 
intervention? either showed an increase in aerobic capacity values, necessitating a familiarization 
session (Swindburn et al., 1985), or they showed no significant difference in aerobic capcity 
values meaning that a familiarization session was not needed (Cox et al., 1989).  
 
Significant Increase in Aerobic Capacity Variables 
The following discusses a few of the studies that found an increase in aerobic capacity, 
which necessitates a familiarization session. One study by Swindburn in a clinical population had 
subjects perform a 12-minute walking test, a paced step test, as well as a cycle ergometer test. 
This study found that there was a progressive and significant increase in performance in all three 
types of exercise test between the first and fourth measurements. The overall changes in 
performance were: a 96% increase in steps climbed, 29% longer cycling duration, and a 16% 
improvement in 12 MWD (Swindburn et al., 1985). This indicates that up to 4 familiarization 
sessions may be needed in order to mitigate increases not due to the intervention! Unless you 
think there may be a training effect going on, which seems like a possibility to me. How long 
was the gap between tests in the other studies? This would allow you to compare. 
A study by Elborn et al. (1990) had subjects with cardiac function impairment performed 
3 cardiopulmonary exercise tests with at least 2 weeks of separation between each test. Changes 
over the three tests at rest, at a submaximal intensity, and at maximal intensity were analyzed. 
This study shows that all the parameters measured during a cardiopulmonary exercise test at rest 
and during symptom-limited exercise were reproducible between a second and third test as 
compared with the first test. The first exposure of patients with chronic cardiac failure to an 
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exercise test such as this resulted in an underestimate of exercise time by about 20%, which 
argues strongly for the importance of familiarization as shown here that the values were not 
reliable until the second testing session. Patients also achieved a higher exercise stage in test 2 
compared to the first, despite their perceived exertion being similar. Peak exercise VO2, VCO2 
and VE were also significantly underestimated between the first and second test (Elborn et al., 
1990). 
 
No Significant Increase in Aerobic Capacity Variables 
The following discusses a few of the studies that found no significant increase in aerobic 
capacity, which would mean that a familiarization session is not needed. Cox et al. designed a 
study to examine the reproducibility and the learning effect of an incremental exercise testing. 
Specifically, Cox and colleagues studied cycle ergometer testing in patients with obstructive lung 
disease who were untrained, and who also had never done such a test prior to this study. This 
study was designed in a test retest fashion, as the subjects performed the first test then the second 
test 24 hours after. This study found that there were no significant differences between values of 
the first and second testing procedure. This indicates that there was in fact no learning effect that 
occurred during this cycle ergometer test. Results indicated good reproducibility for workload 
(4.5%), VO2Max (3.5%), RER (3.4%), and HR (3.7%) (Cox et al., 1989). 
In a healthy population, Fielding et al. also investigated the reproducibility of maximal 
exercises tests, specifically in older women. Women from 51 to 68 years old were used for this 
study, which is similar to the population used in this study. Each subject performed 5 different 
exercise tests separated by at least 1 week’s time. Subjects performed the Modified Bruce 
protocol on a motor driven treadmill. VO2Max values were found to be consistent between all 
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tests, with the mean coefficient of variation being 6.5%. Mean maximal ventilation was also not 
significantly different between tests. RER and maximal HR reached between tests was also not 
significant. In addition, intraclass correlation coefficients for a single test are high and suggest 
good agreement between tests. In general, the associations did improve between test 2, test 3 and 
test 4. This study concluded that the Bruce treadmill protocol for women who are older (51-68 
years old) produces highly reproducible results with VO2Max, maximum heart rate, as well as 
ventilation. It is suggested that performance of only a single VO2Max test is sufficient to assess 
aerobic capacity in middle-aged and older women (Fielding et al., 1997).  
 
Summary 
What these studies conclude is that in clinical populations a familiarization session is 
needed as these values can increase up until the fourth test. This increase up until the fourth test 
means that incorrect values of aerobic capacity may be obtained if taken in the first three tests. 
This necessitates a thorough familiarization session in order to properly instruct subjects on what 
they are doing so that they feel comfortable with performing what is being asked of them. While 
this familiarization session is important for every population, it may be even more important for 
clinical populations in which the accuracy of these exercise values may be a matter of life and 
death.  In healthy older women there may not be a learning effect as Fielding et al. showed high 
reproducibility. However no study has shown a decrease in VO2Max values. This study did also 
show that RER and HRMax had no significant difference between pre and post-test. Because the 
current study showed that VO2Max both relative and absolute all showed significant decreases 
from visit 2 to visit 3, it can be speculated that visit 1’s familiarization session was somewhat 
effective. However, it can be speculated, that in this population, during the 2-week period 
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between visit 2 and visit 3, there was some de-familiarization with the test procedure; that 
forgotten knowledge of the tasks to be performed explains the decrements. However an 
alternative hypothesis is that the participants simply lost motivation. A maximal effort exercise 
test is difficult for anyone, especially those who are considered sedentary.. It is possible that they 
completed the first test and found out how hard the test actually was. This may have led to some 
hesitation and holding back of the same effort during the subsequent testing session. It is also 
possible that during the last session the participants were ready to end their time commitment to 
the study as 3 weeks is long time to commit oneself to a study. Some of these tests also took part 
near the end of the school year, which may have also been a factor in subjects losing motivation. 
This would mean that a learning effect was in fact mitigated through visit 1, however the 
opposite effect may have occurred in the 2-week period between visit 2 and 3 since the first visit 
was so thorough in the sense that the participants were instructed on everything to do, free to ask 
questions regarding the tasks, and allowed to redo portions of the test if their first attempt was 
not adequate. Also the second test was a week after the familiarization, which lessens the 
possibility of forgotten information, compared to the post test that was 3 weeks after the 
familiarization session. What this would mean in the context of the Wagoner et al. study, since 
the same familiarization session was performed, is that the increases observed in VO2Max was in 
fact related to the strength protocol and not a learning effect; meaning that there may have also 
been a decrease in the Wagoner study, but this decrease was counterbalanced by the resistance 
training. With such as small sample size, these are all speculative at this time and a larger sample 
is needed to confirm of refute these preliminary study results.  
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When discussing the exploratory variables, the changes in muscular strength, EMG 
amplitude, and muscle size (CSA) observed from this study, it is important to mention that 
because a resistance training protocol was not a direct part of this study, it is not one of the main 
variables in question for this current study. However because of the Wagoner et al. study’s 
hypotheses focused on these variables, these varilables were measured in order to provide means 
for direct comparison as this study was designed to serve as the control group for Wagoner’s 
study. Specifically, Wagoner’s hypotheses two, three, and four, that stated peak torque (PT) and 
EMG amplitude would siginificantly increase whereas CSA would not in response to the training 
intervention. Wagoner found that PT and EMG amplitude significantly increased from pre to 
post intervention whereas CSA of the VL did not. Wagoner concluded that observed increases in 
PT and EMG ampiltude were a result of increased neural activation and recruitment of muslce 
fibers considering that VL CSA did not increase in a hypertrophic way. With no changes 
observed in this current study for PT, EMG amplitude and CSA, which was expected, the 
improvements in some of these variables preseted by Wagoner et al study, may have beed 
attributed to the study strength training intervention. Once again, due to the small sampel size of 
the currect study, a larger sample size is necessary to confirm or refute this possibility.  
 
Conclusion 
This current study found that there was a significant decrease in VO2Max from pre to post-
test in middle age sedentary women. This is a suprising result that may be explained in part by a 
potential de-familiarization of the women between pre and post-test, a long window between pre 
and post test, as well as a possible loss of motivation. However, the resuls of this preliminary 
evalution should be cautiously interpreted due to the small sample size. Nevertheless, these 
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preliminary results appears to support the fact that a familiarization session is indeed important 
in this population and that a 2-week period may be enough to diminish the familiarization effect 
thus potentially requiring familiarization procedure to be implemented prior to each test. 
 
Future Research  
 This study is one of the few of its kind in terms of the population chosen to observe as 
well as the type of results obtained in that VO2Max actually decreased . Future investigations 
exploring the influence of performing an additional familiarization session when the time 
between pre and post test is long is warranted. Furthermore, specificity in terms of the mode 
these tests are performed (treadmill vs. cycle ergometer) would be insightful to see how the 
mode of the test can influence the learning effect especially since treadmill walking/running may 
be a more natural pattern for most. Lastly, given the results of this study, this learning effect 
should be explored in different populations such as breast cancer population to see how this 
etiology affects aerobic capacity and strength measurements, especially given the wasting nature 
of this disease. 
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APPENDIX 1.1: STUDY BROCHURE 
 VOLUNTEERS NEEDED FOR RESEARCH STUDY 
 
VOLUNTEERS NEEDED FOR RESE 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Subjects needed for study that is investigating the effect of a 
familiarization session on aerobic capacity in sedentary females. 
 
• Searching for volunteers that are female adults between the ages of 35-65 
years.  
• Must not have participated in regularly scheduled exercise (< 2 times / week) 
within the past 6 months.  
• Participation involves 3 total visits: 
o Visit 1  approximately 2 hours (Familiarization)  
o Visits 2 & 3  approximately 1.5 hour each (Pre and Post Testing) 
• Subjects will undergo 2 cardiopulmonary exercise tests and 2 
isokinetic/isometric tests.  
 
IRB: 15-1129 
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APPENDIX 1.2: PRE-ASSESSMENT GUIDELINES 
 
UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL 
Claudio Battaglini, Ph.D. FACSM. 
Department of Exercise and Sport Sciences 
105 Fetzer  Hall, CB # 8700 
(919) 843-6045 / Email: claudio@email.unc.edu 
 
 
Pre-Test Guidelines 
 
1. Avoid eating 2 hours prior to testing. 
2. Void completely before testing. 
3. Maintain proper hydration prior to testing. 
4. Please wear appropriate clothing/shoes for testing (running shorts/shirt/shoes) 
5. No exercise 12 hours prior to testing. 
6. No alcohol consumption 48 hours prior to testing. 
7. No diuretic medications 7 days prior to testing. 
Source: Advanced Fitness Assessment and Exercise Prescription – Third Edition – Vivian H. Heyward 
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APPENDIX 1.3: Physical Activity Readiness Questionnaire  
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APPENDIX 1.4: MEDICAL HISTORY QUESTIONNAIRE  
Medical History 
 
Subject:__________________________ ID: ___________  Telephone:______________ 
 
Address:________________________________________________________________ 
 
Occupation:___________________________________  Age:______________________ 
 
          YES NO 
Patient History 
1. How would you describe your general health at present? 
Excellent______ Good_______ Fair______ Poor______ 
2.   Do you have any health problems at the present time?   _____ _____ 
3.  If yes, please describe:          
            
4.  Have you ever been told you have heart trouble?    _____ _____ 
5.  If yes, please describe:          
            
6. Is there any chance of you being pregnant at this time?  Yes:   No:   
7. Is there any chance that you may become pregnant during span of the study?  
 Yes:    No:    
8. Have you had consistent menstrual periods for the last 3 
months?                                                      Yes:_________          No:________ 
If no, when was your last period____________________________________ 
9.  Do you ever get pain in your chest?     _____ _____ 
10.  Do you ever feel light-headed or have you ever fainted?   _____ _____ 
11.  If yes, please describe:          
            
12.  Have you ever been told that your blood pressure has been elevated? _____ _____ 
13.  If yes, please describe:          
            
14.  Have you ever had difficulty breathing either at rest or with exertion? _____ _____ 
15.  If yes, please describe:          
            
16.  Are you now, or have you been in the past 5 years, under a doctor’s care for any reason? 
        _____ _____ 
17.  If yes for what reason?          
            
18.  Have you been in the hospital in the past 5 years?   _____ _____ 
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19.  If yes, for what reason?          
            
20.  Have you ever experienced an epileptic seizure or been informed that you have epilepsy? 
        _____ _____ 
21.  Have you ever been treated for infectious mononucleosis, hepatitis, pneumonia, or another 
infectious disease during the past year?    _____ _____ 
22.  If yes, name the disease:          
23.  Have you ever been treated for or told you might have diabetes? _____ _____ 24.  
Have you ever been treated for or told you might or low blood sugar? _____ _____ 
25.  Do you have any known allergies to drugs?    _____ _____ 
26.  If so, what?           
            
27.  Have you ever been “knocked-out” or experienced a concussion? _____ _____ 
28.  If yes, have you been “knocked-out” more than once?   _____ _____ 
29.  Have you ever experienced heat stroke or heat exhaustion?  _____ _____ 
30.  If yes, when?           
            
31.  Have you ever had any additional illnesses or operations? (Other than childhood diseases) 
        _____ _____ 
32.  If yes, please indicate specific illness or operations:      
            
33.  Are you now taking any pills or medications?    _____ _____ 
34.  If yes, please list:           
            
35.  Have you had any recent (within 1 year) difficulties with your: 
 a.  Feet        _____ _____ 
 b.  Legs        _____ _____ 
 c.  Back        _____ _____ 
 
Family History 
36.  Has anyone in your family (grandparent, father, mother, and/or sibling) experienced any of 
the following? 
 a.  Sudden death       _____ _____ 
 b.  Cardiac disease       _____ _____ 
 c.  Marfan’s syndrome      _____ _____ 
 
Mental History 
37.  Have you ever experienced depression?     _____ _____ 
38.  If yes, did you seek the advice of a doctor?    _____ _____ 
39.  Have you ever been told you have or has a doctor diagnosed you with panic disorder, 
obsessive-compulsive disorder, clinical depression, bipolar disorder, or any other psychological 
disease?       _____ _____ 
40.  If yes, please list condition and if you are currently taking any medication. 
Condition      Medication 
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Bone and Joint History 
41.  Have you ever been treated for Osgood-Schlatter’s disease?  _____ _____ 
42.  Have you ever had any injury to your neck involving nerves or  
vertebrae?         _____ _____ 
43.  Have you ever had a shoulder dislocation, separation, or other injury of the shoulder that 
incapacitated you for a week or longer?     _____ _____ 
44.  Have you ever been advised to or have you had surgery to correct a shoulder condition? 
        _____ _____ 
45.  Have you ever experienced any injury to your arms, elbows, or wrists?_____ _____ 
46.  If yes, indicate location and type of injury:       
            
47.  Do you experience pain in your back?     _____ _____ 
48.  Have you ever had an injury to your back?    _____ _____ 
49.  If yes, did you seek the advice of a doctor?    _____ _____ 
50.  Have you ever been told that you injured the ligaments or cartilage of either knee joint? 
         _____ _____ 
51.  Do you think you have a trick knee?     _____ _____ 
52.  Do you have a pin, screw, or plate somewhere in your body as the result of bone or joint 
surgery that presently limits your physical capacity?   _____ ____ 
53.  If yes, indicate where:          
            
54.  Have you ever had a bone graft or spinal fusion?   _____ _____ 
 
Activity History 
55.  During your early childhood (to age 12) would you say you were: 
 Very active ____ Quite active____ Moderately active____ Seldom active____ 
56.  During your adolescent years (age 13-18) would you say you were: 
 Very active ____ Quite active____ Moderately active____ Seldom active____ 
57.  Did you participate in: 
a. Intramural school sports?      _____ _____ 
b. Community sponsored sports?     _____ _____ 
c. Varsity school sports?      _____ _____ 
d. Active family recreation?      _____ _____ 
58.  Since leaving high school, how active have you been? 
 Very active ____ Quite active____  Active____  Inactive____ 
59.  Do you participate in any vigorous activity at present?   _____ _____ 
60.  If yes, please list: 
Activity  Frequency   Duration  Intensity 
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61.  How would you describe your present state of fitness? 
Excellent_____ Good_____ Fair_____ Poor_____ 
62.  Please list the type(s) of work you have been doing for the previous ten years: 
Year  Work    Indoor/Outdoor Location (city/state) 
             
             
             
             
         
63.  Whom shall we notify in case of emergency? 
 Name:            
 Phone: (Home)     (Work)     
 Address:           
64.  Name and address of personal physician:       
             
           
 
All of the above questions have been answered completely and truthfully to the best of my 
knowledge. 
 
Signature:        Date:     
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APPENDIX 1.5: DATA COLLECTION SHEET  
 
 
Subject ID:    
 
Visit 1 
Height (in/cm):       /    Weight (lbs/kg):             /   
 
RBP:          RHR:      
 
 
 
 
Ultrasound Assessment  
 
Half Femur Length (cm):     
 
Pre CSA (cm2):      Post CSA (cm2):      
 
 
 
 
 
Cardiopulmonary Assessment (VO2peak) 
 
Mask Size:      Seat Height (in):     
 
Pre       Post 
RHR(Before):      RHR(Before):    
 
RBP(Before):      RBP(Before):    
 
RHR(After):      RHR(After):    
 
RBP(After):      RBP(After):    
 
Height (cm):      Height (cm):     
 
Weight (kg):       Weight (kg):    
 
VO2peak:       VO2peak: 
      (ml/kg/min)               (ml/kg/min) 
    
  
55
             (L/min)                              (L/min) 
 
Lactate (mmol/L):     Lactate (mmol/L):    
 
Isokinetic / Isometric Strength Testing 
 
Electrode Placement [66% Femur Length](cm):      
 
Isokinetic Leg Extension (60°/sec) CW 
Pre:       Post: 
          (Basic Noise)      (Basic Noise) 
 
           
 
           
 
           
 
Isometric  
Pre:       Post: 
           
 
Gravity Correction 
Pre:        Post: 
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